TABLE 2.
Constructed MERS-CoV RBD fragments containing single or multiple mutations in the RBD of representative MERS-CoV strains isolated in 2012 to 2015 and multiple key mutations in the RBM of the RBD (residues 377 to 588)a
Protein | Yr isolated | Host | Mutation in MERS-CoV RBD residue: |
No. of mutations | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
400 | 424 | 431 | 434 | 457 | 460 | 482 | 506 | 509 | 510 | 511 | 513 | 520 | 522 | 530 | 534 | 582 | ||||
EMC-RBD | 2012 | Human | K | T | A | A | S | S | A | L | D | D | R | E | A | Q | V | V | N | |
2012-RBD | 2012 | Human | F | G | A | 3 | ||||||||||||||
2013-RBD | 2013 | Human | P | V | F | V | I | 5 | ||||||||||||
2014-RBD | 2014 | Human | I | H | 2 | |||||||||||||||
2015-RBD | 2015 | Human | L | 1 | ||||||||||||||||
Camel-RBD | 2013 | Camel | N | S | G | S | 4 | |||||||||||||
RBD-FGG | 2012 | Human | F | G | 3 | |||||||||||||||
2015 | Human | G | ||||||||||||||||||
RBD-FGGAA | 2012 | Human | F | G | 5 | |||||||||||||||
2015 | Human | G | ||||||||||||||||||
Escape mutants | A | |||||||||||||||||||
A |
EMC-RBD, RBD fragment constructed based on the sequence of MERS-CoV EMC2012 (prototype) strain. Key residues in the RBM of the RBD are in bold.